ICON ($ICLR) posted quarterly earnings results on Wednesday, February 19th. The company reported earnings of $3.43 per share, missing estimates of $3.48 by $0.05. The company also reported revenue of $2,041,100,000, missing estimates of $2,076,838,197 by $-35,738,197.
You can see Quiver Quantitative's $ICLR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ICON Hedge Fund Activity
We have seen 253 institutional investors add shares of ICON stock to their portfolio, and 467 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOSTON PARTNERS removed 1,653,122 shares (-72.4%) from their portfolio in Q4 2024, for an estimated $346,676,214
- RUANE, CUNNIFF & GOLDFARB L.P. added 1,265,540 shares (+inf%) to their portfolio in Q4 2024, for an estimated $265,396,393
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,257,039 shares (-99.8%) from their portfolio in Q4 2024, for an estimated $263,613,648
- WELLINGTON MANAGEMENT GROUP LLP removed 968,729 shares (-31.4%) from their portfolio in Q4 2024, for an estimated $203,152,158
- D. E. SHAW & CO., INC. added 950,740 shares (+574.6%) to their portfolio in Q4 2024, for an estimated $199,379,685
- BLACKROCK, INC. removed 888,838 shares (-77.3%) from their portfolio in Q4 2024, for an estimated $186,398,216
- FMR LLC removed 862,694 shares (-39.4%) from their portfolio in Q4 2024, for an estimated $180,915,558
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ICON Congressional Stock Trading
Members of Congress have traded $ICLR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ICLR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOHN JAMES sold up to $15,000 on 09/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
